Thema Fachgebiet Ansprechperson Lindenhofgruppe Kooperationspartner / Sponsor The role of CD163 as a marker of disease activity in neovascular AMD (2020-02483) Ophthalmologie Prof. Dr. med. Justus G. Garweg Hamid Ahmadieh (Deputy Director of Research, Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran); Ali Hafezi-Moghadam (Harvard Medical School) Aqueous Humor, Blood and Imaging Biomarker Study with DME, AMD AND Cataract Patients (2021-01625) Ophthalmologie Prof. Dr. med. Justus G. Garweg Hoffmann-La Roche Mediators influencing vascular and retinal neurodegeneration in diabetes – a pilot study (2021-00248) Ophthalmologie Prof. Dr. med. Justus G. Garweg Hoffmann-La Roche Biophysical and Functional Analysis and Characterization of Retinal Retention Approaches (2021-02498) Ophthalmologie Prof. Dr. med. Justus G. Garweg Hoffmann-La Roche Aqueous Humor, Blood and Imaging Biomarker Study with DME, AMD AND Cataract Patients (2021-01625) Ophthalmologie Prof. Dr. med. Justus G. Garweg Hoffmann-La Roche Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration (FALCON CRTH258ADE01) Ophthalmologie Prof. Dr. med. Justus G. Garweg Novartis Pharmaceuticals Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration (FALCON CRTH258ADE01) Ophthalmologie Prof. Dr. med. Justus G. Garweg Novartis Pharmaceuticals Cytokines as Biomarkers of early neuroretinal degeneration in diabetic retinopathy (Diabetes and mediators influencing early vascular and neurodegeneration in the retina 2018-00286) Ophthalmologie Prof. Dr. med. Justus G. Garweg New approach to minimally invasive glaucoma surgery (Effekt einer Zyklodialyse zusätzlich zur Trabekulektomie ab interno (Trabektom-Operation) in der Behandlung chronischer Offenwinkelglaukome (2021-01341)) Ophthalmologie Prof. Dr. med. Justus G. Garweg Supportive effect of intravitreal corticosteroids in neovascular AMD insufficiently responsive to anti-VEGF drugs (Real-Life Outcomes of adjunct intravitreal Dexamethasone Implant in Patients treated with anti-VEGF for Diabetic Macular Edema and Exudative Age-Related Macular Degeneration) Ophthalmologie Prof. Dr. med. Justus G. Garweg Kammerwasser- und Glaskörperdiagnostik bei Augenerkrankungen mit möglicher entzündlicher Komponente (2019-00651) Ophthalmologie Prof. Dr. med. Justus G. Garweg Prospektive Kohortenstudie zum Vergleich verschiedener anti-VEGF-Therapien (2020-01847) Ophthalmologie Prof. Dr. med. Justus G. Garweg 90 Geschäftsbericht 2022 Lindenhofgruppe Lehre und Forschung
RkJQdWJsaXNoZXIy MzQxOTE=